These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 2978923)
1. Veto cells are not responsible for alloimmunization-induced abrogation of lethal graft-versus-host reaction. Halle-Pannenko O; Bruley-Rosset M; Pritchard LL Transplant Proc; 1987 Feb; 19(1 Pt 1):549-50. PubMed ID: 2978923 [No Abstract] [Full Text] [Related]
2. Comparison of the repertoire of T-cell lines and clones specific for minor histocompatibility antigens derived from immunized mice and from mice developing a graft-versus-host reaction. Bruley-Rosset M; Miconnet I; Roger T; Seman M; Halle-Pannenko O Transplant Proc; 1993 Feb; 25(1 Pt 1):94-5. PubMed ID: 8438503 [No Abstract] [Full Text] [Related]
4. Peripheral tolerance specific for host minor histocompatibility antigens in acute GVHR-protected mice is associated with functional deletion of CD4+ but not CD8+ T cells and an active suppressive mechanism. Miconnet I; Bruley-Rosset M; Halle-Pannenko O Transplant Proc; 1993 Feb; 25(1 Pt 1):327-8. PubMed ID: 8438320 [No Abstract] [Full Text] [Related]
5. A class II antigen-specific T cell clone can suppress graft-versus-host reactivity in murine allogeneic bone marrow chimeras. Shih CC; Truitt RL Transplant Proc; 1987 Feb; 19(1 Pt 3):2664-7. PubMed ID: 2950639 [No Abstract] [Full Text] [Related]
6. Reconstitution of lymphoid tissues under the influence of a subclinical level of graft versus host reaction induced by bone marrow T cells or splenic T cell subsets. Hirano M; Arase H; Arase-Fukushi N; Ogasawara K; Iwabuchi K; Miyazaki T; Good RA; Onoé K Cell Immunol; 1993 Oct; 151(1):118-32. PubMed ID: 8402923 [TBL] [Abstract][Full Text] [Related]
7. Dominant role of Mlsa antigens in the induction of unresponsiveness to non-H-2 antigens. Berumen L; Pritchard LL; Goutner A; Halle-Pannenko O Transplant Proc; 1987 Feb; 19(1 Pt 1):506-7. PubMed ID: 3152703 [No Abstract] [Full Text] [Related]
8. The influence of graft-versus-host reactivity, lymphocyte depletion, and cell dose on allogeneic bone marrow engraftment. Glass B; Uharek L; Gaska T; Gassmann W; Löffler H; Müller-Ruchholtz W Bone Marrow Transplant; 1993; 12 Suppl 3():S41-7. PubMed ID: 8124257 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of graft-versus-host-reaction (GVHR) by in vitro incubation of donor lymphocytes with thymic or splenic chalone (s). Kiger N; Florentin I; Garcia-Giralt E; Mathé G Exp Hematol; 1973; 1(1):22-8. PubMed ID: 4153630 [No Abstract] [Full Text] [Related]
10. Lymphokine production in vivo in a murine graft-versus-host reaction. Troutt AB; Kelso A Transplant Proc; 1992 Oct; 24(5):2317. PubMed ID: 1413076 [No Abstract] [Full Text] [Related]
12. Photochemical treatment with S-59 psoralen and ultraviolet A light to control the fate of naive or primed T lymphocytes in vivo after allogeneic bone marrow transplantation. Truitt RL; Johnson BD; Hanke C; Talib S; Hearst JE J Immunol; 1999 Nov; 163(9):5145-56. PubMed ID: 10528221 [TBL] [Abstract][Full Text] [Related]
13. Abrogation of bone marrow allograft resistance in mice by increased total body irradiation correlates with eradication of host clonable T cells and alloreactive cytotoxic precursors. Schwartz E; Lapidot T; Gozes D; Singer TS; Reisner Y J Immunol; 1987 Jan; 138(2):460-5. PubMed ID: 3098843 [TBL] [Abstract][Full Text] [Related]
14. Phenotypic and functional analysis of T cells derived from mice developing a lethal graft-versus-host reaction (GVHR) to non-H-2 antigens. Bruley-Rosset M; Bonardelle D; Churaqui E; Halle-Pannenko O Transplant Proc; 1989 Feb; 21(1 Pt 3):3039-41. PubMed ID: 2468251 [No Abstract] [Full Text] [Related]
15. Delayed infusion of normal donor cells after MHC-matched bone marrow transplantation provides an antileukemia reaction without graft-versus-host disease. Johnson BD; Drobyski WR; Truitt RL Bone Marrow Transplant; 1993 Apr; 11(4):329-36. PubMed ID: 8485480 [TBL] [Abstract][Full Text] [Related]
16. [Emergency problems of the graft vs host reaction (literature survey)]. Shevelev AS Probl Gematol Pereliv Krovi; 1976 Apr; 21(4):35-41. PubMed ID: 16257 [No Abstract] [Full Text] [Related]
17. Mitigation of graft-versus-host disease in mice by treatment of donors with bacterial endotoxin. Rose WC; Rodey GE; Rimm AA; Truitt RL; Bortin MM Exp Hematol; 1976 Mar; 4(2):90-6. PubMed ID: 4335 [TBL] [Abstract][Full Text] [Related]
18. Graft versus leukemia. 3. Apparent independent anthost and antileukemia activity of transplanted immunocompetent cells. Bortin MM; Rimm AA; Saltzstein EC; Rodey GE Transplantation; 1973 Sep; 16(3):182-8. PubMed ID: 4147030 [No Abstract] [Full Text] [Related]
19. Anti-recipient cytotoxic T lymphocyte precursors are present in the spleens of mice with acute graft versus host disease due to minor histocompatibility antigens. Hamilton BL; Bevan MJ; Parkman R J Immunol; 1981 Feb; 126(2):621-5. PubMed ID: 6450246 [TBL] [Abstract][Full Text] [Related]
20. [Immunological studies in experimental bone marrow transplantation]. Onoe K Gan No Rinsho; 1989 May; Spec No():279-86. PubMed ID: 2689667 [No Abstract] [Full Text] [Related] [Next] [New Search]